Trial Profile
Open-label Study to Evaluate the Effects of Once Daily Extraneal (7.5% Icodextrin) Peritoneal Dialysis Solution on Triglyceride Levels in Peritoneal Dialysis Patients
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2017
Price :
$35
*
At a glance
- Drugs Icodextrin (Primary)
- Indications Hyperglycaemia
- Focus Therapeutic Use
- Sponsors Baxter Healthcare Corporation
- 10 May 2017 New trial record